GainersToday.com
GainersToday.com, Tracking Stock Market Picks
Enter Symbol:
 
Aeterna Zentaris, Inc. (AEZS) [hlAlert]

Rating:
Outperform
AEZS
down 99.37 %

Aeterna Zentaris, Inc. (AEZS) rated Outperform with price target $5.50 by Oppenheimer

Posted on: Tuesday,  Jun 7, 2011  8:25 AM ET by Oppenheimer

Oppenheimer rated Outperform Aeterna Zentaris, Inc. (NASDAQ: AEZS) on 06/07/2011, when the stock price was $14.46. Since
then, Aeterna Zentaris, Inc. has lost 99.38% as of 12/02/2015's recent price of $0.09.
If you would have followed this Oppenheimer's recommendation on AEZS, you would have lost 99.37% of your investment in 1639 days.

AEterna Zentaris Inc. is a global biopharmaceutical company focused on endocrine therapy and oncology. The product pipeline of the Company encompasses compounds at all stages of development, from drug discovery through marketed products. The Company’s principal product candidates include cetrorelix for benign prostatic hyperplasia (BPH) and AEZS-108 for endometrial and ovarian cancers. In January 2007, the Company completed the spin-off of Atrium Biotechnologies Inc., known as Atrium Innovations (Atrium). On November 30, 2007, the Company completed the sale of its Utah-based subsidiary, Echelon Biosciences Inc. (Echelon), to Frontier Scientific Inc.

OppenheimerFunds, Inc. has been helping investors achieve their financial goals since 1960. We are one of the nation's largest and most respected asset management companies. At OppenheimerFunds, we believe that in order for you to reach your financial goals, your investments must perform. That is why investment excellence—over the long term and across the range of our products—is our highest priority. OppenheimerFunds and its controlled affiliates offer a broad range of products and services to individuals, corporations and institutions, including mutual funds, separately managed accounts, investment management for institutions, hedge fund products, qualified retirement plans and subadvisory investment-management services.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
6/7/2011 8:25 AM Buy
None
14.46 33.00
as of 12/30/2011
1 Week down  -2.53 %
1 Month down  -3.75 %
3 Months up  1.31 %
1 YTD down  -36.09 %

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy